Which bacteria are lacking in depression?

Understanding the correlation between gut health and mental wellness has gained significant attention in recent years. Depression, once solely attributed to neurochemical imbalances, is now being explored through a more systemic lens, including the state of the gut microbiome. Scientific studies suggest that disruptions in gut bacteria—often termed “depression bacteria” when referred to in this context—could influence the development and persistence of depressive symptoms. This blog navigates the world of gut health, investigating which bacterial strains are commonly lacking in those suffering from depression and the implications of these deficiencies. We'll also discuss how gut microbiome testing can be used as a tool to identify microbial imbalances and target interventions that promote mental well-being.

Depression Bacteria: Key Microorganisms Relevant to Gut Microbiome Testing

When discussing “depression bacteria,” we’re referring to bacteria in the gut microbiome that play crucial roles in mood regulation, emotional resilience, and neurochemical balance. These bacteria are not pathogens but symbiotic organisms that contribute to our physiological and psychological health. Their absence or depletion can result in or exacerbate mental health challenges, particularly depression.

Studies have indicated that gut residents like Lactobacillus and Bifidobacterium species exert a protective effect against mood disorders. These bacteria aid in the production of neuroactive compounds, help reduce systemic inflammation, and maintain the integrity of the intestinal lining, which is crucial to prevent the “leaky gut” phenomenon often seen in depressed patients. Equally important are short-chain fatty acid (SCFA)-producing bacteria such as Faecalibacterium prausnitzii and those in the Lachnospiraceae family, which maintain anti-inflammatory environments within the gut.

Gut microbiome testing has become a powerful diagnostic tool for identifying imbalances in these helpful microbial populations. Brands like InnerBuddies offer microbiome analysis kits that provide individuals with detailed bacterial profiles. These allow healthcare professionals and users alike to determine which bacteria are present, which are lacking, and how their levels compare to a healthy baseline. Such testing is especially valuable for individuals dealing with treatment-resistant or recurring depression, providing actionable insights into biological contributors that conventional psychiatric treatments might overlook.

By evaluating the presence and abundance of “depression-fighting” bacteria, users can make informed decisions around lifestyle changes, dietary interventions, and probiotic supplementation that may help restore microbial balance and reduce depressive symptoms.

Gut Microbiota Imbalance and Its Role in Depression

The human gut is a complex ecosystem comprising trillions of microorganisms working together to maintain physical and mental health. When this ecosystem is in equilibrium—a state termed “eubiosis”—it supports not only digestion and immunity but also neurochemical balance. However, when this balance is disrupted, leading to an overgrowth of harmful bacteria and a decline in beneficial ones, the result is a condition called gut dysbiosis. This dysbiosis is closely linked to various mental health disorders, including major depressive disorder (MDD).

Gut microbiota influences the central nervous system (CNS) via the gut-brain axis—a bidirectional communication channel involving neurotransmitters, cytokines, vagus nerve signaling, and microbial metabolites. Disruption in this axis can contribute to mood disorders. For instance, approximately 90% of the body’s serotonin—a neurotransmitter essential for regulating mood, appetite, and sleep—is produced in the gut. When the microbiota responsible for serotonin synthesis are depleted or outcompeted by pathogenic bacteria, the resulting serotonin deficiency can manifest as depressive symptoms.

Several studies have pinpointed specific microbial signatures in depressed individuals. For example, a 2015 study published in the journal Nature observed that people with depression often had reduced levels of Faecalibacterium and Coprococcus species, while having increased levels of potentially harmful bacteria like Eggerthella and Clostridium. These shifts not only reduce the production of beneficial metabolites but also promote inflammatory responses, leading to systemic inflammation that can affect brain function and contribute to depressive episodes.

Furthermore, chronic inflammation stemming from gut dysbiosis can interfere with the hypothalamic–pituitary–adrenal (HPA) axis, the body's central stress response system. Dysregulation of the HPA axis is a hallmark of depression and has been associated with increased cortisol levels, reduced resilience to stress, and a higher risk of mood disorders.

This connection emphasizes the importance of identifying and correcting gut imbalances. Through advanced tools like the InnerBuddies gut microbiome test, individuals can detect deviations from the microbial norms linked to psychological well-being and take proactive steps toward rebalancing their ecosystem for improved mental health outcomes.

Microbial Deficiency in Depression: Which Bacteria Are Missing?

A growing body of research has focused on pinpointing specific bacterial genera and species that are commonly deficient in individuals struggling with depression. These microbes are frequently involved in the synthesis and regulation of critical neurochemicals and anti-inflammatory molecules that influence mood.

1. Lactobacillus spp. – These are well-known probiotic bacteria prominently found in the human gastrointestinal tract. They produce gamma-aminobutyric acid (GABA), a neurotransmitter that promotes calmness and reduces anxiety. Several animal studies have demonstrated that depletion of Lactobacillus species can lead to decreased GABA receptor expression in the brain, resulting in heightened stress and depressive behaviors.

2. Bifidobacterium spp. – Another cornerstone of a healthy gut, Bifidobacterium species help maintain intestinal barrier integrity and reduce low-grade inflammation, both of which are vital for mental health. Specific strains like Bifidobacterium longum have been associated with improvements in depression and anxiety-like behaviors in both animal models and human clinical trials.

3. Faecalibacterium prausnitzii – This anaerobic bacterium belongs to the Firmicutes phylum and is one of the major producers of butyrate, a short-chain fatty acid that has anti-inflammatory properties. Lower levels of F. prausnitzii have been consistently reported in patients with major depressive disorder, especially those suffering from gastrointestinal symptoms.

4. Coprococcus spp. – This genus also contributes to the production of SCFAs like butyrate. A 2019 paper published in Nature Microbiology associated high levels of Coprococcus with enhanced mental well-being scores, while their depletion correlated strongly with feelings of depression.

5. Roseburia spp. – Another butyrate-producing genus, Roseburia is admired not only for its anti-inflammatory roles but also for supporting serotonin production. Low levels are associated with both metabolic and psychological disorders.

The deficiency of these microbes can impair the gut’s ability to synthesize essential compounds like serotonin, dopamine, and butyrate, while simultaneously increasing vulnerability to inflammation and stress. It is through the lens of this microbial depletion that gut microbiome testing gains its therapeutic relevance—by identifying what’s missing, we can cultivate strategies and interventions to bring these microbial allies back into balance.

Depressive Gut Bacteria Profile: What Does It Look Like?

The gut microbiome profile of a person with depression typically shows a pattern of reduced microbial diversity and a disproportionate abundance of harmful or pro-inflammatory bacteria. This profile is distinctive enough that researchers are increasingly exploring the feasibility of using it as a biomarker for early diagnosis and intervention in mood disorders.

An average healthy gut features a complex and balanced bouquet of bacteria critical for digestion, immune modulation, and neurochemical interaction. Conversely, the depressive gut microbial profile often reveals deficiencies in the ‘good’ bacteria we previously discussed—such as Lactobacillus, Bifidobacterium, Faecalibacterium, and Coprococcus. These are often accompanied by a rise in the taxa of genera like Oscillibacter, Eggerthella, Clostridium XVIII, and Alistipes, which have been linked with inflammation and neurotoxicity.

These pathogenic or pro-inflammatory microbes produce harmful metabolites such as lipopolysaccharides (LPS), which contribute to leaky gut syndrome. When the gut lining becomes permeable, LPS and other toxins enter the bloodstream and reach the brain, triggering neuroinflammation—a known factor in the pathophysiology of depression.

Innovative tools like the InnerBuddies microbiome test can produce detailed reports outlining these microbiotic imbalances. These reports not only indicate the presence or scarcity of depression-fighting microbes but also give insight into the functions that are likely compromised—whether that’s neurotransmitter production, inflammation regulation, or barrier protection.

In clinical terms, a depressive microbiota profile is akin to a red flag, signaling a deviation from eubiosis and a shift towards a state that can endanger mental and physical health. As our understanding of microbial profiles advances, the potential for precise, microbiome-informed mental health care grows stronger.

Microbiome Depletion and Mood: The Consequences of Missing Microbes

Microbiome depletion refers to the loss or significant reduction of microbial populations essential for health. In the context of depression, the effects of this depletion manifest both psychologically and systemically. Reduced microbial density and diversity are among the hallmarks of depressive states, and several consequences follow from this imbalance.

One of the most profound consequences is lowered synthesis of mood-related neurotransmitters such as serotonin, dopamine, and GABA—all of which rely on microbial participation or byproducts to be manufactured efficiently. In animal studies, germ-free mice—those raised without exposure to any microbes—displayed increased anxiety and depression-like behaviors, further indicating the necessity of gut microbes in stabilizing emotions.

Another detrimental outcome of microbial depletion is the rise in systemic inflammation. With fewer beneficial microbes producing anti-inflammatory SCFAs like butyrate and propionate, there’s less suppression of inflammatory cytokines, known contributors to depression symptoms via neuroinflammation. Cytokines like interleukin-1β and tumor necrosis factor-alpha (TNF-α) have been found in elevated levels in those with major depressive disorder.

Additionally, certain bacteria modulate the expression of tight junction proteins that keep the gut lining intact. A reduction in these bacteria—such as Faecalibacterium and Roseburia—can increase gut permeability. Enhanced permeability allows pathogens and endotoxins to reach the brain, compromising the blood-brain barrier and affecting brain chemistry.

Finally, microbiome depletion weakens the immune system and impairs nutrient absorption. Without sufficient microbes aiding in vitamin B12, folate, and magnesium synthesis and absorption, the brain becomes vulnerable to various deficiencies known to deteriorate mood and cognitive capacity.

This body of evidence cements the idea that microbiome depletion isn't just a gut issue—it’s a systemic condition with potential to affect nearly every facet of health, particularly mental health. By turning to tools like the InnerBuddies gut microbiome test, individuals can track microbial depletion and develop strategies to bolster their ecosystem and emotional well-being.

Bacterial Strains Linked to Depression: Which Are Typically Lacking?

Beyond general bacterial species, multiple specific strains within broad categories like Lactobacillus and Bifidobacterium have shown notable potential in alleviating depressive symptoms when present in sufficient quantities. Identifying these strains is vital not only for understanding depression pathology but also for guiding supplementation and treatment strategies.

1. Lactobacillus plantarum 299v – Known for its intestine-colonizing abilities and GABA production, this strain has exhibited antidepressant-like effects in rodent studies and increased serotonin receptor expression. In human trials, subjects showed reduced levels of cortisol and perceived stress after supplementing with this strain.

2. Bifidobacterium longum NCC3001 – One of the most researched strains in mood modulation, this bacterium has been shown to normalize anxiety-like behaviors in mice and improve quality of life in humans experiencing irritable bowel syndrome and depressive symptoms.

3. Lactobacillus rhamnosus JB-1 – Known for improving the microbiota-gut-brain axis signaling, this strain modulates the expression of GABA receptors in the brain and induces anxiety-reducing effects.

4. Bifidobacterium breve CCFM1025 – A newer entry in the psychobiotic space, this strain interacts with the HPA axis and reduces stress-induced inflammation, showing promise in trials for mood stabilization.

Clinical trials and meta-analyses now show that combinations of these strains, when taken as “psychobiotics,” provide statistically significant mood improvements in individuals with mild to moderate depression. While strains differ in efficacy and individual compatibility, personalized testing through microbiome analysis kits like InnerBuddies can identify which strains are necessary or deficient for each user, allowing for targeted intervention through supplementation or dietary modification.

Practical Implications: Using Gut Microbiome Testing to Address Bacterial Deficiencies

With increasing evidence linking microbiota to depression, gut microbiome testing stands out as a powerful diagnostic and therapeutic instrument. Practical applications of these tests allow clinicians and patients alike to understand microbiota deficiency patterns and implement individualized strategies to restore microbial harmony.

The InnerBuddies microbiome test offers at-home sampling and lab-based bacterial DNA analysis. The resulting data highlight which bacteria are overrepresented, which are underrepresented, and how that composition compares to a healthy microbial baseline. These reports often also include functional insights—i.e., what pathways are affected such as SCFA production, mucin degradation, or neurotransmitter synthesis.

Upon recognizing deficiencies in depression-protective bacteria, users can adopt diverse strategies for correction:

• Probiotic Supplementation – Targeting depleted strains of Lactobacillus or Bifidobacterium through high-quality psychobiotic formulations.
• Prebiotic Foods and Fibers – Including fibers that serve as substrates for beneficial bacterial growth, such as inulin, resistant starch, and beta-glucans.
• Fermented Foods – Incorporating live-culture foods like kefir, kimchi, and sauerkraut enriches the gut with naturally occurring psychobiotics.
• Lifestyle Changes – Stress management, sleep hygiene, and regular physical activity all contribute to microbiome restoration.

Perhaps the most promising implication is the potential for personalized psychobiotic therapeutics guided by real-time microbiota data. As research expands and tools evolve, microbiome-informed protocols may offer a complementary or even primary treatment route for individuals resistant to traditional antidepressants.

Conclusion

The emerging science of the gut-brain axis is reshaping our understanding of depression, positioning the microbiome as a pivotal factor in emotional health. Key “depression bacteria” such as Lactobacillus, Bifidobacterium, Faecalibacterium, and their strain-level variants play crucial roles in neurotransmitter production, inflammation control, and barrier permeability. Their deficiency contributes to the onset and persistence of depressive symptoms.

Gut microbiome testing, such as those offered by InnerBuddies, provides actionable insights into these microbial imbalances. Through diagnostics and informed interventions, individuals can take charge of their mental health in a more personalized, holistic way.

Q&A Section

Q1: What gut bacteria are most commonly missing in depression?
A: Key missing bacteria in people with depression often include Lactobacillus, Bifidobacterium, Faecalibacterium prausnitzii, Coprococcus, and Roseburia.

Q2: Can gut microbiome testing help treat depression?
A: Yes. Gut microbiome testing, such as the one from InnerBuddies, helps identify missing beneficial bacteria and offers guidance for targeted interventions like probiotics and diet.

Q3: How does gut dysbiosis affect mood?
A: Gut dysbiosis affects neurotransmitter synthesis, increases inflammation, and disrupts the gut-brain axis—factors that strongly contribute to mood disorders including depression.

Q4: Are probiotics effective for depression?
A: Certain probiotic strains—such as Lactobacillus plantarum and Bifidobacterium longum—have shown effectiveness in reducing symptoms of depression, especially when guided by microbiome testing.

Important Keywords

• depression bacteria
• gut microbiome depression
• gut health mental health
• microbiome test for depression
• missing bacteria in depression
• Lactobacillus and depression
• gut-brain axis
• psychobiotics
• microbiome imbalance
• InnerBuddies microbiome test